Disclosures for "Interpreter Modality, Not Language, Impacts Door-to-needle Times in Acute Ischemic Stroke: A Telestroke Subgroup Analysis"
-
Author has nothing to disclose
-
Dr. Sambursky has nothing to disclose.
-
Ms. McCoy has nothing to disclose.
-
Lan Gao has nothing to disclose.
-
Ms. Mayer has nothing to disclose.
-
Dr. Sevilis has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sevilis Neurology Consulting, LLV. Dr. Sevilis has or had stock in Moderna.